Development and Evaluation of “YEN FIGHT DIABETES ’’ digital model for Comprehensive and Holistic Diabetes Care at Yenepoya Medical College Hospital for Prevention and Management of Diabetes Mellitus
Funding Agency : no
Ongoing
Primary Investigator
Nil
2021 -
2022
A Randomized , Double –blind ,Placibo-controlled ,Multicenter Study to Demonstrate the effects of Sotagliflozin on Cardiovascular and Renal Events in Type 2 Diabetes . The SCORED trial.
Funding Agency : Sanofi
Ongoing
Co Investigator
500000
2019 -
2021
A Comparative study of inflammatory markers and biochemical parameters among Diabetic and Non Diabetic patients with COVID – 19 and their influence on the disease outcome in tertiary care hospital of coastal Karnataka.
Funding Agency : self
Ongoing
Primary Investigator
20000
2020 -
2021
Development and Evaluation of “YEN FIGHT DIABETES ’’ digital model for Comprehensive and Holistic Diabetes Care at Yenepoya Medical College Hospital for Prevention and Management of Diabetes Mellitus
A Randomized , Double –blind ,Placibo-controlled ,Multicenter Study to Demonstrate the effects of Sotagliflozin on Cardiovascular and Renal Events in Type 2 Diabetes . The SCORED trial.
A Comparative study of inflammatory markers and biochemical parameters among Diabetic and Non Diabetic patients with COVID – 19 and their influence on the disease outcome in tertiary care hospital of coastal Karnataka.